165 related articles for article (PubMed ID: 6124402)
21. A comparison of diphenylhydantoin metabolism in different tissues using high performance liquid chromatography.
MacKinney AA; Shinnick FL; Gorder C
Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):395-411. PubMed ID: 7122986
[TBL] [Abstract][Full Text] [Related]
22. Studies by biointeraction chromatography of binding by phenytoin metabolites to human serum albumin.
Ohnmacht CM; Chen S; Tong Z; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 836(1-2):83-91. PubMed ID: 16621742
[TBL] [Abstract][Full Text] [Related]
23. Absolute configurations of the dihydrodiol metabolites of 5,5-diphenylhydantoin (phenytoin) from rat, dog, and human urine.
Maguire JH; Butler TC; Dudley KH
Drug Metab Dispos; 1980; 8(5):325-31. PubMed ID: 6107230
[TBL] [Abstract][Full Text] [Related]
24. The effect of pregnancy on the biliary excretion of [14C]phenytoin in the rat.
Vore M; Soliven E; Blunden M
J Pharmacol Exp Ther; 1979 Feb; 208(2):257-62. PubMed ID: 762658
[TBL] [Abstract][Full Text] [Related]
25. UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin.
Kim PM; Winn LM; Parman T; Wells PG
J Pharmacol Exp Ther; 1997 Jan; 280(1):200-9. PubMed ID: 8996197
[TBL] [Abstract][Full Text] [Related]
26. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
27. The fate of orally administered [4-14C]phenytoin in two healthy male volunteers.
Kadar D; Fecycz TD; Kalow W
Can J Physiol Pharmacol; 1983 Apr; 61(4):403-7. PubMed ID: 6861002
[TBL] [Abstract][Full Text] [Related]
28. The effect of estradiol-17 beta treatment on the metabolism and biliary excretion of phenytoin in the isolated perfused rat liver and in vivo.
Vore M; Montgomery C
J Pharmacol Exp Ther; 1980 Oct; 215(1):71-6. PubMed ID: 7452491
[TBL] [Abstract][Full Text] [Related]
29. Effect of isoniazid on the metabolism of 14C-diphenylhydantoin in rats.
Buttar HS; Wong LT; Moffatt JH
Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):9-18. PubMed ID: 736695
[TBL] [Abstract][Full Text] [Related]
30. 1-Acetyl-3-acetoxy-5'5-diphenylhydantoin has colchicine-like activity.
MacKinney AA; Vyas R; Mueller C
Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):251-64. PubMed ID: 6739954
[TBL] [Abstract][Full Text] [Related]
31. Dose-dependence of the apparent half-life of phenytoin in the rat.
Vicuna A; Lalka D; duSouich P; Vicuna N; Ludden TM; McLean AJ
Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):3-11. PubMed ID: 7394315
[TBL] [Abstract][Full Text] [Related]
32. Phenytoin teratogenesis: correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue.
Martz F; Failinger C; Blake DA
J Pharmacol Exp Ther; 1977 Oct; 203(1):231-9. PubMed ID: 909055
[TBL] [Abstract][Full Text] [Related]
33. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Prakash C; Kamel A; Gummerus J; Wilner K
Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
[TBL] [Abstract][Full Text] [Related]
34. Quantification of phenytoin and its metabolites in equine plasma and urine using high-performance liquid chromatography.
Guan F; Uboh CE; Soma LR; Birks EK; Teleis D; Rudy JA; Watson AO; Tsang DS
J Chromatogr B Biomed Sci Appl; 2000 Sep; 746(2):209-18. PubMed ID: 11076073
[TBL] [Abstract][Full Text] [Related]
35. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
36. Interactions between folate metabolism, phenytoin metabolism, and liver microsomal cytochrome P450.
Billings RE
Drug Nutr Interact; 1984; 3(1):21-32. PubMed ID: 6510238
[TBL] [Abstract][Full Text] [Related]
37. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
[TBL] [Abstract][Full Text] [Related]
38. The effects of phenytoin and its metabolite 5-(4-hydroxyphenyl)-5-phenylhydantoin on cellular glucose transport.
Wong HY; Chu TS; Chan YW; Fok TF; Fung LW; Fung KP; Ho YY
Life Sci; 2005 Mar; 76(16):1859-72. PubMed ID: 15698863
[TBL] [Abstract][Full Text] [Related]
39. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
40. Phenytoin metabolism in the cat after long-term oral administration.
Hassell TM; Maguire JH; Cooper CG; Johnson PT
Epilepsia; 1984 Oct; 25(5):556-63. PubMed ID: 6479107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
